内皮機能不全の病理学的メカニズムと臨床研究の進展
Zhuoran Wang1, Yuqiao Yang1, Quan Wang1
1Department of Anesthesiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Frontiers in cardiovascular medicine
|February 20, 2026
まとめ
心血管疾患と代謝疾患の重要な要因である内皮機能不全 (ED) は,酸化窒素の減少や酸化ストレスなどの分子変化を含む. このレビューは,EDの詳細を記載しています.
科学分野:
- 心血管研究 循環器科の研究
- 内皮細胞生物学 エンドセル生物学
- メタボリック障害 メタボリック障害
背景:
- 内皮機能不全 (ED) は,心血管疾患および代謝疾患における中心的な病理学的メカニズムとしてますます認識されています.
- 最近の研究は,その重要な役割を強調し,包括的な理解を必要としています.
研究 の 目的:
- 内皮機能不全の詳細な概要,その定義,分子機構,および関連する条件を含む.
- EDの管理のための現在のおよび新興の治療戦略を探求する.
- 診断,予防,治療のための実践的なガイドラインを提供すること.
主な方法:
- 内皮機能不全に関する基礎的および臨床研究に関する包括的な文献レビュー.
- 分子機構,臨床関連,バイオマーカー,治療介入の分析.
- 最近の科学的発見と臨床的発見の統合.
主要な成果:
- EDには,酸化窒素の生物利用度低下,酸化ストレス,炎症,エンドセリアル-メゼンキーマ移行などのメカニズムが含まれています.
- EDは糖尿病,動脈硬化症,脳血管疾患,阻害性睡眠時無呼吸症に関連しています.
- 小分子,幹細胞,遺伝子療法を含む様々なバイオマーカーと治療戦略が議論されています.
結論:
- EDのメカニズムと臨床的影響を徹底的に理解することは,効果的な管理に不可欠です.
- このレビューは,EDの診断,予防,治療のための枠組みを確立しています.
- 研究成果の統合は,医療従事者のための実践的なガイドラインを提供します.
関連する概念動画
Coronary Artery Disease II: Pathophysiology
670
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
670
Coronary Artery Disease I: Introduction
1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Peripheral Artery Disease I: Introduction
426
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
426
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Atherosclerosis I: Introduction
1.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K
Regulation of Angiogenesis and Blood Supply
3.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.7K


